Tagged With Gilead Sciences Stock

Gilead rises after pricing its coronavirus-fighting drug remdesivir


Gilead slides 4% after coronavirus drug shows limited benefit in moderately ill patients


Gilead surges 17% on report that drug shows effectiveness against COVID-19



One Wall Street firm says approval for Gilead's experimental coronavirus treatment is a coin-flip bet at best — but still thinks you should buy the stock right now


A small group of scientists, execs, and VCs are $277 million richer as their companies race to create a coronavirus vaccine. Here are 7 who have raked in huge sums.


Drug developer Gilead soars to 16-month high after WHO official says its experimental treatment is best shot for fighting coronavirus



Gilead Sciences spikes after human trials start on a possible coronavirus treatment